Optimal medical decision making requires consideration of efficacy and toxicity data, patient preferences and cost-effectiveness information. Working examining the synthesis of these considerations into actual choices made by patients and clinicians is limited. The candidate will focus her research on this interface of outcomes data and clinical decision making using bone marrow transplantation as a model. The specific research aims of this proposal are to: 1. Examine the knowledge, values, expectations and decision making processes of patients undergoing bone marrow transplantation using a prospective, longitudinal, questionnaire-based design. Results will allow her to analyze the influence of these considerations on decision making. 2. Use decision analytic techniques to synthesize the complex trade-offs inherent in the use of unrelated donor bone marrow transplantation for the treatment of chronic myelogenous leukemia. Results will be used to determine the best method of communicating complex outcome information to assist patient and clinician decision making. Completion of these projects will improve our understanding of how and why patients make health care decisions that what can be done to assist them in making difficult choices. In addition, this proposal will give the candidate experience in study design and implementation, decision analysis, instrument development, and measurement of pateint preferences. This research will be conducted in the Center for Outcomes and Policy Research, an environment supported by faculty from the Harvard School of Public Health, the Dana-Farber Cancer Institute, the Harvard Center for Risk Analysis, and the Brigham and Women's Hospital. These collaborations will assure interactions vital to the success of these projects and to the candidate's career. Since medical decision making also requires an understanding of efficacy data and the psychology of decision making, classwork at the Harvard School of Public Health will provide exposure to case-control and cohort studies, meta-analysis, biostatistics, decision theory and risk analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
5K07CA075267-04
Application #
6173453
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1997-09-01
Project End
2002-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
4
Fiscal Year
2000
Total Cost
$82,025
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Joffe, Steven; Mello, Michelle M; Cook, E Francis et al. (2007) Advance care planning in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant 13:65-73
Andorsky, D J; Loberiza, F R; Lee, S J (2006) Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation. Bone Marrow Transplant 37:889-95
Lee, Stephanie J; Vogelsang, Georgia; Flowers, Mary E D (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9:215-33
Lee, Stephanie J; Loberiza, Fausto R; Rizzo, J Douglas et al. (2003) Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 9:389-96
Lee, Stephanie J; Zahrieh, David; Alyea, Edwin P et al. (2002) Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs. Blood 100:2697-702
Lee, Stephanie k; Cook, E Francis; Soiffer, Robert et al. (2002) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 8:444-52
Lee, Stephanie J; Klein, John P; Barrett, A John et al. (2002) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100:406-14
Loberiza Jr, Fausto R; Rizzo, J Douglas; Bredeson, Christopher N et al. (2002) Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20:2118-26
Lee, S J; Fairclough, D; Parsons, S K et al. (2001) Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol 19:242-52
Lee, S J; Klein, J P; Anasetti, C et al. (2001) The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. Blood 98:3205-11

Showing the most recent 10 out of 17 publications